POSTER SESSION IV
Tuesday, March 23, 2010   1:00 PM - 4:30 PM
Exhibit Hall
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
ENDOCRINE PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
32
A Study of Parathyroid Transcription Factor GCM2 Expression in Parathyroid Lesions
(579)
D Nonaka - New York University School of Medicine, New York, NY
Factors Contributing to Nuclear Bubbling and Clearing Mimicking the Features of Papillary Thyroid Carcinoma
(560)
S Ehdaivand, LC Noble, WO Greaves, EN Trudeau, MC Morin, LJ Wang, RA DeLellis - Lifespan Academic Medical Center and Alpert Medical School at Brown University, Providence, RI
Cancer Stem Cells Markers in Human Thyroid Tumorigenesis: Role of p63 in Anaplastic Thyroid Carcinoma
(570)
AR Laury, C Nucera, V Nose - Brigham & Women's Hospital, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, MA
Comparison of MicroRNA Expression in Thyroid Neoplasms: An Aid for Diagnostic Evaluation?
(572)
Y Li, GA Barkan, S Alkan - Loyola University Medical Center, Maywood, IL; Miami, Miami, FL
Molecular and Morphologic Characterization of Thyroid Carcinomas According to Extra-Thyroid Extension Status
(584)
M Rivera, J Ricarte-Filho, J Knauf, RM Tuttle, J Fagin, R Ghossein - Memorial Sloan-Kettering Cancer Center, NY
Molecular and Histopathological Features of Multifocal Papillary Thyroid Carcinomas
(556)
M Bansal, G Mantha, YE Nikiforov - University of Pittsburgh, Pittsburgh, PA
PAX-8 Is a Sensitive Marker for Thyroid Differentiation. Comparison with PAX-2, TTF-1, and Thyroglobulin
(573)
N Liles, G Hamilton, SS Shen, B Krishnan, LD Truong - The Methodist Hospital, Houston, TX; Baylor College of Medicine, Houston, TX
The Value of Thyroid Atypia of Undetermined Significance Terminology and Its Follow-Up by Repeat FNA
(590)
SH Zydowicz, A Kemp, E Lucas, X Lin, R Nayar - Northwestern University, Chicago, IL
BRAFV600E Mutation Analysis of Liquid Based Preparation-Processed Fine-Needle Aspiration Sample Improves the Diagnosis of Papillary Thyroid Carcinoma
(557)
HY Chang, A Kim, H Kim, H Lee, BH Kim - Korea University, Guro Hospital, Seoul, Korea
Management and Outcome of 141 Patients with Thyroid Nodules with Cytological Diagnosis of Indeterminate Significance
(571)
SH Lee, TS Hwang, SK Kim, HS Han, SD Lim, WS Kim, YS Ko - Konkuk University School of Medicine and Konkuk University Medical Center, Seoul, Republic of Korea
Oxyphilic Hypercellular Follicular Nodule of the Thyroid: A 10 Year Experience
(580)
AL Patton, SP Gmitro, JA Brainard - Cleveland Clinic, Cleveland, OH
Claudin Proteins, PAX8 and NIS Immunohistochemical Evaluation in Human Fetal Thyroid Development
(558)
C Colato, MC Ambrosetti, A Dardano, F Monzani, S Filetti, M Chilosi, F Menestrina, M Ferdeghini - University of Verona, Verona, Italy; University of Pisa, Pisa, Italy; University La Sapienza, Roma, Italy
Papillary Thyroid Carcinoma with Prominent Hobnail Features: A New Aggressive Variant of Moderately Differentiated Papillary Carcinoma - A Clinicopathological, Immunohistochemical and Molecular Study of 8 Cases
(555)
S Asioli, LA Erickson, TJ Sebo, J Zhang, L Jin, GB Thompson, RV Lloyd - Mayo Clinic, Rochester, MN; Turin University, Italy
Epidermal Growth Factor Receptor Over-Expression in Thyroid Neoplasia Associates with Chromosome 7 Polysomy
(589)
MD Williams, ME Cabanillas, GL Clayman - UT MD Anderson Cancer Center, Houston, TX
RAS Mutation Is an Early Event in the Development of the Follicular Variant of Papillary Carcinoma and May Predispose to Subsequent Genetic Alterations
(559)
B Deslouches, MN Nikiforova, L Niemeier, YE Nikiforov - University of Pittsburgh, Pittsburgh, PA
CDX2 Expression in Columnar Cell Variant of Papillary Thyroid Carcinoma
(561)
ML Enriquez, LB Ende, PJ Zhang, KT Montone, VA LiVolsi - Hospital of the University of Pennsylvania, Philadelphia, PA
The Use of Genetic Programming for Diagnostic Texture Analysis in the Assessment of Follicular Variant Papillary Thyroid Carcinoma: A Feasibility Study
(577)
O Mete, I Pressman, B Potetz, SL Asa - University Health Network, Toronto, Canada; Fields Institute for Research in the Mathematical Sciences, Toronto, Canada; University of Kansas, Lawrence
Specific MicroRNAs Differentiate between Adrenocortical Adenomas and Carcinomas
(562)
M Feinmesser, C Benbassat, G Toren-Haritan, N Barabash, T Drozd, Y Spector - Rabin Medical Center, Beilinson Hospital, Sackler School of Medicine, Tel Aviv University, Petah Tiqva, Israel; Rosetta Genomics, Rehovot, Israel
Comparative Immunohistochemical Detection of Somatostatin Receptor 2a and Dopamine Receptor in Pituitary Adenomas for New Therapeutic Strategies
(565)
C Inomoto, H Hirabayashi, M Takei, A Teramoto, RY Osamura - Tokai University School of Medicine, Isehara, Kanagawa, Japan; Nippon Medical School, Sendagi Bunkyo-ku, Tokyo, Japan
Carboxyl Ester Lipase Expression in Normal Pituitary Gland and Pituitary Adenomas. Possible Role in the Modulation of Hormone Secretion Via Ceramide Pathway
(569)
S La Rosa, C Placidi, S Uccella, G Finzi, D Vigetti, M Losa, C Capella - Ospedale di Circolo, Varese, Italy; University of Insubria, Varese, Italy; Istituto Scientifico San Raffaele, Milan, Italy
High Incidence of Immunohistochemical SSTR2a Expression in Gastro-Entero-Pancreatic Neuroendocrine Tumors: Studies on Primary and Metastatic Diseases
(563)
H Hirabayashi, C Inomoto, K Hirabayashi, RY Osamura - Tokai University School of Medicine, Isehara, Kanagawa, Japan
Lipid-Rich Neuroendocrine Tumors "Carcinoids) of the Appendix: Potential Confusion with Goblet Cell Carcinoid
(585)
S Serra, R Chetty - University Health Network/University of Toronto, Toronto, Canada